ETB scientists bring unique expertise and diverse interests to research projects and collaborations to help kick-start the early discovery pathway. The team creates tools and technologies that enable the de-risking of potential targets and modalities for treating diseases. Learn more about ETB.
-
Research
-
- Funding & Notices
-
Early Translation Branch (ETB)
High-Throughput Screening Helps Advance Melanoma Therapy
Finding the right compounds for new uses in treating a disease or improving a therapeutic approach can be time consuming. To speed up the process, NCATS scientists used high-throughput screening to help advance a therapy for melanoma.
OpenData Portal: Sharing Data to Advance COVID-19 Research
NCATS created a new resource for scientists, the OpenData Portal, to openly and quickly share COVID-19-related drug repurposing data and experiments for all approved drugs.
Reprogramming Immune Cells to Fight Tumors
Immunotherapy holds immense power in harnessing the body’s immune system to fight diseases. Researchers have shown a novel type of immune therapy can reprogram immune cells to stop tumor growth and kill cancer cells.
About ETBFind out more about how ETB experts help discover novel small molecule therapies across the spectrum of human diseases.
Scientific CapabilitiesAccess a collaborative team of experts in assay development, high-throughput screening, medicinal chemistry, informatics and drug development.
Work with ETBLearn how to collaborate with ETB staff to pursue a drug target or screen of interest.
Find out more about how ETB experts help discover novel small molecule therapies across the spectrum of human diseases.
Access a collaborative team of experts in assay development, high-throughput screening, medicinal chemistry, informatics and drug development.
Learn how to collaborate with ETB staff to pursue a drug target or screen of interest.
Work with Us
ETB is highly collaborative and always encourages new partnership opportunities, including projects with NIH and external researchers as well as disease foundations and biotechnology companies. Learn more about how to work with us.
Looking for a chemical probe?
ETB experts have developed many small molecule probes for further therapeutic development.
NCATS Programs & Initiatives
- Funding & Notices
-
